<DOC>
	<DOCNO>NCT00824707</DOCNO>
	<brief_summary>This study work research efficacy significant anti-virus therapy unresectable Hepatitis B virus ( HBV ) relate primary liver cancer ( PLC ) establish treatment standard anti-virus therapy PLC .</brief_summary>
	<brief_title>Efficacy Significance Antiviral Therapy Unresectable Hepatitis B Virus-related Primary Liver Cancer</brief_title>
	<detailed_description>primary liver cancer ( PLC ) one world 's common malignancy , especially East-Asian countries.Hepatitis B virus ( HBV ) infection associate 70-90 % PLC case China . PLC develop stage natural course chronic HBV infection anti-virus therapy consider management PLC . However , definite guide practice anti-virus therapy , especially unresectable inoperable PLC . Because fact , research significant anti-virus therapy HBV-related PLC urgently need . 200 patient randomly assign anti-virus therapy group control gruop.The time progression ( TTP ) overall survival within two year use evaluate effect anti-virus therapy PLC . The aim study research efficacy significant anti-virus therapy unresectable HBV-related PLC establish treatment standard anti-virus therapy PLC .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>1 . Identify patient PLC accordance clinical diagnostic criterion PLC.Patients PLC shall diagnose without pathology . It appropriate perform liver resection operation . 2. serum positive HBsAg≥6 month . 3 . Criteria liver function : Child A B level , serum total bilirubin ≤ 1.5 time upper limit normal value , alanine aminotransferase aspartate aminotransferase ≤ 10 time upper limit normal value . 4. hemoglobin≥8.5g/dl , PTINR≤2.3 PT &gt; 6 second normal value . 5 . No dysfunction major organ ; Blood routine , kidney function , cardiac function lung function basically normal . 6 . Patients understand trial , male female , age 1870 voluntarily participate clinical trial sign information consent . 1 . Patients apparent cardiac , pulmonary , cerebric renal dysfunction , may affect treatment liver cancer . 2 . Patients disease may affect treatment mention . 3 . Patients medical history malignant tumor . 4 . Subjects participate clinical trial . 5 . Women pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>primary liver cancer</keyword>
	<keyword>hepatitis B virus</keyword>
	<keyword>anti-virus therapy</keyword>
</DOC>